Livzon Pharmaceutical Group Inc (000513) — Financial Flexibility Index
Livzon Pharmaceutical Group Inc (000513) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of CN¥962.25 Million (operating CF CN¥853.59 Million minus capex CN¥108.66 Million) represents 0% of total liabilities (CN¥9.17 Billion). Also explore how fast is Livzon Pharmaceutical Group Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Livzon Pharmaceutical Group Inc Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for Livzon Pharmaceutical Group Inc across 27 annual periods. Check strategic asset allocation of Livzon Pharmaceutical Group Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Livzon Pharmaceutical Group Inc (1998–2024)
Year-by-year free cash flow to debt coverage for Livzon Pharmaceutical Group Inc. For the full company profile including market capitalisation, see 000513 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.37x | CN¥3.55 Billion | CN¥2.98 Billion | CN¥9.55 Billion | ▼ -9.4% |
| 2023 | 0.41x | CN¥4.21 Billion | CN¥3.39 Billion | CN¥10.28 Billion | ▲ +9.7% |
| 2022 | 0.37x | CN¥3.71 Billion | CN¥2.77 Billion | CN¥9.93 Billion | ▼ -6.1% |
| 2021 | 0.40x | CN¥3.21 Billion | CN¥1.90 Billion | CN¥8.06 Billion | ▼ -1.4% |
| 2020 | 0.40x | CN¥2.81 Billion | CN¥2.16 Billion | CN¥6.95 Billion | ▲ +6.4% |
| 2019 | 0.38x | CN¥2.17 Billion | CN¥1.77 Billion | CN¥5.70 Billion | ▲ +24.0% |
| 2018 | 0.31x | CN¥1.74 Billion | CN¥1.27 Billion | CN¥5.69 Billion | ▼ -11.3% |
| 2017 | 0.35x | CN¥1.61 Billion | CN¥1.32 Billion | CN¥4.66 Billion | ▼ -28.3% |
| 2016 | 0.48x | CN¥1.65 Billion | CN¥1.28 Billion | CN¥3.42 Billion | ▲ +11.9% |
| 2015 | 0.43x | CN¥1.40 Billion | CN¥927.79 Million | CN¥3.27 Billion | ▲ +0.1% |
| 2014 | 0.43x | CN¥1.38 Billion | CN¥717.39 Million | CN¥3.22 Billion | ▼ -6.5% |
| 2013 | 0.46x | CN¥1.36 Billion | CN¥439.99 Million | CN¥2.96 Billion | ▼ -16.9% |
| 2012 | 0.55x | CN¥1.36 Billion | CN¥593.96 Million | CN¥2.45 Billion | ▼ -16.8% |
| 2011 | 0.66x | CN¥1.06 Billion | CN¥708.20 Million | CN¥1.59 Billion | ▼ -30.0% |
| 2010 | 0.95x | CN¥970.25 Million | CN¥633.30 Million | CN¥1.02 Billion | ▲ +36.2% |
| 2009 | 0.70x | CN¥626.29 Million | CN¥494.88 Million | CN¥898.92 Million | ▲ +80.4% |
| 2008 | 0.39x | CN¥420.70 Million | CN¥345.18 Million | CN¥1.09 Billion | ▲ +8.5% |
| 2007 | 0.36x | CN¥339.83 Million | CN¥248.55 Million | CN¥954.80 Million | ▼ -5.5% |
| 2006 | 0.38x | CN¥406.91 Million | CN¥226.46 Million | CN¥1.08 Billion | ▼ -16.6% |
| 2005 | 0.45x | CN¥417.79 Million | CN¥161.07 Million | CN¥925.20 Million | ▲ +41.8% |
| 2004 | 0.32x | CN¥327.94 Million | CN¥181.46 Million | CN¥1.03 Billion | ▼ -24.7% |
| 2003 | 0.42x | CN¥403.57 Million | CN¥300.01 Million | CN¥954.70 Million | ▼ -3.1% |
| 2002 | 0.44x | CN¥317.27 Million | CN¥213.65 Million | CN¥727.05 Million | ▲ +17.9% |
| 2001 | 0.37x | CN¥236.63 Million | CN¥155.15 Million | CN¥639.37 Million | ▲ +115.1% |
| 2000 | 0.17x | CN¥100.01 Million | CN¥38.52 Million | CN¥581.24 Million | ▼ -68.6% |
| 1999 | 0.55x | CN¥319.67 Million | CN¥246.23 Million | CN¥583.95 Million | ▲ +1900.9% |
| 1998 | 0.03x | CN¥13.53 Million | CN¥-18.21 Million | CN¥494.51 Million | — |